These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37725855)

  • 21. A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma.
    Guo D; Zhang X; Du X; Yao W; Shen W; Zhu S
    BMC Med Genomics; 2023 Feb; 16(1):27. PubMed ID: 36803971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Comprehensive Analysis of Alterations in DNA Damage Repair Pathways Reveals a Potential Way to Enhance the Radio-Sensitivity of Esophageal Squamous Cell Cancer.
    Wang G; Guo S; Zhang W; Li Z; Xu J; Li D; Wang Y; Zhan Q
    Front Oncol; 2020; 10():575711. PubMed ID: 33178606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma.
    Zhang D; Zhao F; Li J; Qin X; Li S; Niu R
    Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of DNA damage repair in squamous cell carcinoma subtypes.
    Qin F; Sun Y; Deng K; Qin J; Xu Z; Wei J; Yuan L; Zheng T; Li S
    Life Sci; 2021 Aug; 278():119559. PubMed ID: 33932441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptomics based multi-dimensional characterization and drug screen in esophageal squamous cell carcinoma.
    Li Y; Xu F; Chen F; Chen Y; Ge D; Zhang S; Lu C
    EBioMedicine; 2021 Aug; 70():103510. PubMed ID: 34365093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development.
    Lu T; Xu R; Wang CH; Zhao JY; Peng B; Wang J; Zhang LY
    Front Genet; 2022; 13():853113. PubMed ID: 35734437
    [No Abstract]   [Full Text] [Related]  

  • 27. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
    Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
    Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic Profiling of Chinese Cervical Cancer Patients Reveals Prevalence of DNA Damage Repair Gene Alterations and Related Hypoxia Feature.
    Wen H; Guo QH; Zhou XL; Wu XH; Li J
    Front Oncol; 2021; 11():792003. PubMed ID: 35071000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RAP80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinoma.
    Yang Q; Lin W; Liu Z; Zhu J; Huang N; Cui Z; Han Z; Pan Q; Goel A; Sun F
    Cell Death Dis; 2018 Feb; 9(2):146. PubMed ID: 29396516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of immunophenotypes in esophageal squamous cell carcinoma based on immune gene sets.
    Song D; Wei Y; Hu Y; Sun Y; Liu M; Ren Q; Hu Z; Guo Q; Wang Y; Zhou Y
    Clin Transl Oncol; 2022 Jun; 24(6):1100-1114. PubMed ID: 35098447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-omics analyses unravel DNA damage repair-related clusters in breast cancer with experimental validation.
    Liu P; Deng X; Zhou H; Xie J; Kong Y; Zou Y; Yang A; Li X
    Front Immunol; 2023; 14():1297180. PubMed ID: 38022619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular subtyping of esophageal squamous cell carcinoma by large-scale transcriptional profiling: Characterization, therapeutic targets, and prognostic value.
    Wang D; Dai J; Suo C; Wang S; Zhang Y; Chen X
    Front Genet; 2022; 13():1033214. PubMed ID: 36425064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA Damage Repair Profiles Alteration Characterize a Hepatocellular Carcinoma Subtype With Unique Molecular and Clinicopathologic Features.
    Lin P; Gao RZ; Wen R; He Y; Yang H
    Front Immunol; 2021; 12():715460. PubMed ID: 34456923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of prognostic and immunotherapeutic responses in esophageal squamous carcinoma based on hypoxia phenotype-related genes.
    Xie K; Chen Z; Feng J; Pan L; Wang N; Luo J; Yao Y; Ma H; Feng Y; Jiang W
    Front Pharmacol; 2024; 15():1344317. PubMed ID: 38515846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unveiling the prognostic significance of SOX5 in esophageal squamous cell carcinoma: a comprehensive bioinformatic and experimental analysis.
    Li C; Zhang J; Bi Y
    Aging (Albany NY); 2023 Aug; 15(15):7565-7582. PubMed ID: 37531195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma.
    Wu M; Wang Y; Yang D; Gong Y; Rao F; Liu R; Danna Y; Li J; Fan J; Chen J; Zhang W; Zhan Q
    EBioMedicine; 2019 Mar; 41():244-255. PubMed ID: 30876762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive single-cell transcriptomic profiling reveals molecular subtypes and prognostic biomarkers with implications for targeted therapy in esophageal squamous cell carcinoma.
    Zhang D; Zhao F; Li J; Guo P; Liu H; Lu T; Li S; Li Z; Li Y
    Transl Oncol; 2024 Jun; 44():101948. PubMed ID: 38582059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.